Used in cancer immunotherapy research to block the interaction between SIRPα and CD47, enhancing macrophage-mediated phagocytosis of tumor cells. Supports development of therapies aimed at improving immune system recognition and destruction of cancer cells. Commonly applied in functional assays, flow cytometry, and in vivo studies to evaluate immune checkpoint inhibition.